|
|
Name: |
MPM ONCOLOGY IMPACT MANAGEMENT LP |
City: |
CAMBRIDGE |
State: |
MA |
Zip: |
02142 |
|
|
|
Achive
data |
View
Filing Period: |
|
|
|
|
|
|
Download |
|
|
|
|
|
Free Registration Required For Full Results
|
|
|
Holdings
Found :
34 |
|
View All Holdings |
Currently
Viewing:
ALL |
|
|
Page 1 of 1 |
Menu
|
Ticker |
Company Name |
Position Rank |
New/Closed Postion |
Last Close |
Value |
Shares Held |
% of Portfolio |
Value Change |
Change In Shares Held |
% of Company |
Industry |
|
CGEM |
Cullinan Oncology Ord Shs |
1 |
- |
$0.00 |
$77,936,000 |
7,648,268 |
18.23% |
8,719,000 |
0 |
17.574 |
N/A |
|
IOVA |
Iovance Biotherapeutics Inc |
2 |
- |
$11.64 |
$26,743,000 |
3,289,470 |
6.26% |
11,785,000 |
2,073 |
1.538 |
N/A |
|
OLMA |
Olema Pharmaceuticals, Inc. |
3 |
- |
$0.00 |
$26,056,000 |
1,857,136 |
6.1% |
3,114,000 |
-545 |
4.623 |
N/A |
|
GERN |
Geron Corporation |
4 |
- |
$3.79 |
$22,610,000 |
10,715,620 |
5.29% |
-100,000 |
3,139 |
3.132 |
Drug Manufacturers - ... |
|
ITOS |
Iteos Therapeutics, Inc. |
5 |
- |
$0.00 |
$19,118,000 |
1,745,943 |
4.47% |
0 |
0 |
4.599 |
N/A |
|
ALXO |
Alx Oncology Holdings Inc |
6 |
New |
$0.00 |
$18,832,000 |
1,264,759 |
4.41% |
18,832,000 |
1,264,759 |
2.539 |
N/A |
|
MLTX |
Multisys Language Solutions... |
7 |
- |
$0.00 |
$17,789,000 |
294,576 |
4.16% |
1,020,000 |
386 |
0.717 |
N/A |
|
CRNX |
Crinetics Pharmaceuticals, ... |
8 |
- |
$42.12 |
$17,016,000 |
478,234 |
3.98% |
2,769,000 |
-819 |
0.824 |
N/A |
|
KRTX |
Karuna Therapeutics, Inc. |
9 |
- |
$0.00 |
$16,863,000 |
53,279 |
3.95% |
7,866,000 |
69 |
0.132 |
N/A |
|
INSM |
Insmed Inc |
10 |
- |
$24.80 |
$16,367,000 |
528,150 |
3.83% |
3,049,000 |
692 |
0.348 |
Biotechnology |
|
CBAY |
Cymabay Therapeutics, Inc. |
11 |
- |
$32.48 |
$14,436,000 |
611,181 |
3.38% |
5,329,000 |
411 |
0.645 |
N/A |
|
RPTX |
Repare Therapeutics Inc. |
12 |
- |
$0.00 |
$11,971,000 |
1,639,849 |
2.8% |
-7,838,000 |
0 |
4.462 |
N/A |
|
NTLA |
Intellia Therapeutics, Inc. |
13 |
- |
$20.76 |
$11,665,000 |
382,598 |
2.73% |
-5,556,000 |
-162,041 |
0.427 |
N/A |
|
FOLD |
Amicus Therapeutics Inc |
14 |
- |
$10.61 |
$10,158,000 |
715,883 |
2.38% |
1,450,000 |
-256 |
0.21 |
Biotechnology |
|
RGNX |
Regenxbio Inc. |
15 |
- |
$16.19 |
$9,856,000 |
549,078 |
2.31% |
-954,000 |
-107,640 |
1.468 |
N/A |
|
MDGL |
Madrigal Pharmaceuticals Inc |
16 |
- |
$193.33 |
$9,466,000 |
40,910 |
2.21% |
3,499,000 |
51 |
0.247 |
Diagnostic Substances |
|
GPCR |
Structure Therapeutics Inc. |
17 |
- |
$38.94 |
$9,403,000 |
230,696 |
2.2% |
-2,232,000 |
-65 |
0.603 |
N/A |
|
AVDL |
AVADEL Pharmaceuticals Plc |
18 |
- |
$15.99 |
$9,390,000 |
664,986 |
2.2% |
2,548,000 |
762 |
1.142 |
Drug Delivery |
|
MORF |
Morphic Holding, Inc. |
19 |
- |
$28.07 |
$9,350,000 |
323,742 |
2.19% |
4,768,000 |
123,742 |
0.841 |
N/A |
|
HOWL |
Werewolf Therapeutics, Inc. |
20 |
- |
$0.00 |
$9,218,000 |
2,388,011 |
2.16% |
4,108,000 |
0 |
8.662 |
N/A |
|
RLAY |
Relay Therapeutics, Inc. |
21 |
- |
$6.37 |
$9,161,000 |
832,017 |
2.14% |
-2,210,000 |
-520,116 |
0.615 |
N/A |
|
XERS |
Xeris Pharmaceuticals Inc |
22 |
- |
$1.75 |
$9,041,000 |
3,847,232 |
2.12% |
1,623,000 |
-140,735 |
2.839 |
N/A |
|
VERV |
Verve Therapeutics, Inc. |
23 |
- |
$0.00 |
$8,896,000 |
638,163 |
2.08% |
-2,480,000 |
-219,777 |
0.96 |
N/A |
|
RVMD |
Revolution Medicines, Inc. |
24 |
- |
$35.96 |
$7,841,000 |
273,408 |
1.83% |
273,000 |
0 |
0.239 |
N/A |
|
AXSM |
Axsome Therapeutics, Inc. |
25 |
- |
$71.71 |
$7,433,000 |
93,387 |
1.74% |
892,000 |
-199 |
0.25 |
N/A |
|
VKTX |
Viking Therapeutics, Inc. |
26 |
- |
$74.31 |
$6,054,000 |
325,284 |
1.42% |
2,456,000 |
284 |
0.446 |
N/A |
|
ADAP |
Adaptimmune Therapeutics PLC |
27 |
- |
$1.08 |
$4,041,000 |
5,095,912 |
0.95% |
66,000 |
0 |
3.295 |
N/A |
|
HARP |
Harpoon Therapeutics, Inc. |
28 |
- |
$0.89 |
$3,635,000 |
319,670 |
0.85% |
2,347,000 |
0 |
0.978 |
N/A |
|
IRON |
Disc Medicine, Inc |
29 |
New |
$27.55 |
$2,888,000 |
50,000 |
0.68% |
2,888,000 |
50,000 |
0.287 |
N/A |
|
VRDN |
Viridian Therapeutics Ors Shs |
30 |
- |
$12.88 |
$2,178,000 |
100,000 |
0.51% |
-1,739,000 |
-155,323 |
0.221 |
N/A |
|
INZY |
Inozyme Pharma, Inc. |
31 |
- |
$0.00 |
$1,379,000 |
323,813 |
0.32% |
6,000 |
-3,108 |
0.524 |
N/A |
|
PHAT |
Phathom Pharmaceuticals, Inc. |
32 |
- |
$0.00 |
$639,000 |
70,000 |
0.15% |
-2,963,000 |
-277,332 |
0.205 |
N/A |
|
TVTX |
Travere Therapeutics, Inc |
34 |
Closed |
$5.26 |
$0 |
0 |
0% |
-4,942,000 |
-552,846 |
0 |
N/A |
|
KALV |
Kalvista Pharmaceuticals Inc |
33 |
Closed |
$10.78 |
$0 |
0 |
0% |
-5,566,000 |
-577,958 |
0 |
N/A |
|